Bioavailability of Nutrients Contained in Softgel Capsules vs Tablets
NCT ID: NCT01057966
Last Updated: 2012-02-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
15 participants
INTERVENTIONAL
2010-02-28
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Absorption Characteristics of Two Multivitamin Mineral Formulations (Gel vs. Tablet/Capsule)
NCT03146273
Effect of an Oral Supplement Containing Omega-3 and Omega-6 on Dry Eye Symptoms
NCT03265327
Bioavailability of Select Nutrients From Two Formulations of a Multivitamin/Mineral Supplement
NCT05646368
Effectiveness of a Vitamin Mineral Supplement
NCT00153764
Pharmacokinetic Analysis of Nutrient Absorption From a Novel Liposomal Multivitamin/Mineral Formulation
NCT05060367
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ICAPS AREDS Softgel Capsule - Full Strength
ICAPS Eye Vitamin and Mineral Supplement - Softgel
ICAPS Eye Vitamin and Mineral Supplement - Softgel (full strength)
Single full strength dose capsule taken one time
ICAPS AREDS Softgel Capsule - Half Strength
ICAPS Eye Vitamin and Mineral Supplement - Softgel (half -strength)
ICAPS Eye Vitamin and Mineral Supplement - Softgel (half strength)
Single half strength dose capsule taken one time
ICAPS AREDS coated tablets - Full Strength
ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets
ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets (full strength)
Single, full strength dose tablet taken one time
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICAPS Eye Vitamin and Mineral Supplement - Softgel (full strength)
Single full strength dose capsule taken one time
ICAPS Eye Vitamin and Mineral Supplement - Softgel (half strength)
Single half strength dose capsule taken one time
ICAPS Eye Vitamin and Mineral Supplement - Coated Tablets (full strength)
Single, full strength dose tablet taken one time
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Body Mass Index (BMI) 21-27 kg/m2
3. Must be able to give written informed consent
4. Subjects must be willing to comply with all study requirements.
5. Subjects must understand, sign and be given a copy of the written Informed Consent form.
2. Subjects who are pregnant, lactating or planning to be pregnant during the course of the study
3. Subjects with known sensitivity to planned study concomitant medications
4. Subjects participating in any other ophthalmic drug or device clinical trial within 30 days of this clinical investigation.
5. Use of ocular drugs, other than study medications, during the study and within 14 days prior to study entry or any other ocular medication
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Contact Alcon Call Center For Trial Locations
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMA-09-32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.